Insider Transactions Reported by 20 Insiders of ACELYRIN, Inc.

Location
Agoura Hills, CA

Key facts

  • ACELYRIN, Inc. has 20 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

ACELYRIN, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Westlake BioPartners Fund II, L.P. 10%+ Owner $72,519,930 Mixed 09 May 2023
Shao-Lee Lin Chief Executive Officer, Director $10,488,913 Mixed 01 Apr 2024
Paul Peloso Chief Medical Officer $1,189,890 Mixed 04 Oct 2023
Ronald Oyston Chief People Officer $1,047,039 Mixed 09 Jan 2024
Melanie Gloria Chief Operating Officer $582,378 Mixed 23 May 2024
Gil M. Labrucherie CFO and CBO $348,226 Mixed 31 Aug 2024
Sanam Pangali CLO & Head of People $331,468 Mixed 23 May 2024
Mardi Dier CFO and CBO $47,634 Mixed 09 May 2023
AyurMaya Capital Management Company, LP Director, Other*, 10%+ Owner $0 Mixed 21 May 2025
Gosebruch Henry O Director $0 Mixed 21 May 2025
Mina Kim Chief Executive Officer, Director $0 Mixed 21 May 2025
Beth C. Seidenberg Director $0 Mixed 21 May 2025
Daniel J. Becker Director $0 Mixed 21 May 2025
Patrick Machado Director $0 Mixed 21 May 2025
Shephard Mpofu Chief Medical Officer $0 Mixed 21 May 2025
Amar Murugan Chief Legal Officer $0 Mixed 21 May 2025
Dawn Svoronos Director $0 Mixed 21 May 2025
Lynn A. Tetrault Director Mixed 21 May 2025
Alan Colowick Director Mixed 04 May 2023
Bruce C. Cozadd Director Mixed 21 May 2025

Top shareholders of ACELYRIN, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Madison Avenue Partners, LP
13D/G
5.1%
5,089,260
$12,468,687 $0 29 Apr 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
4.7%
4,714,402
$11,550,285 $0 31 Dec 2024
T. Rowe Price Investment Management, Inc.
13D/G
4.6%
4,651,030
$11,395,024 -$20,141,680 28 Feb 2025
CITADEL ADVISORS LLC
13D/G
Kenneth Griffin
4.2%
4,218,748
$10,335,933 $0 31 Dec 2024
Westlake BioPartners Fund II, L.P.
3/4/5
10%+ Owner
class O/S missing
9,790,729
$72,519,930 09 May 2023
Shao-Lee Lin
3/4/5
Chief Executive Officer, Director
mixed-class rows
1,995,942
mixed-class rows
$10,488,913 01 Apr 2024
Paul Peloso
3/4/5
Chief Medical Officer
class O/S missing
160,644
$1,189,890 04 Oct 2023
Ronald Oyston
3/4/5
Chief People Officer
mixed-class rows
264,932
mixed-class rows
$1,047,039 09 Jan 2024
Melanie Gloria
3/4/5
Chief Operating Officer
mixed-class rows
314,328
mixed-class rows
$582,378 23 May 2024
Gil M. Labrucherie
3/4/5
CFO and CBO
mixed-class rows
381,055
mixed-class rows
$348,226 31 Aug 2024
Sanam Pangali
3/4/5
CLO & Head of People
mixed-class rows
403,014
mixed-class rows
$331,468 23 May 2024
Mardi Dier
3/4/5
CFO and CBO
mixed-class rows
91,657
mixed-class rows
$47,634 09 May 2023
Mina Kim
3/4/5
Chief Executive Officer, Director
class O/S missing
1,195,856
21 May 2025
Shephard Mpofu
3/4/5
Chief Medical Officer
class O/S missing
328,860
21 May 2025

Recent Insider Transactions by Companies or Individuals for ACELYRIN, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
AyurMaya Capital Management Company, LP SLRN Common Stock, par value $0.00001 per share ("Common Stock") Disposed to Issuer -100% -9,334,735 0 21 May 2025 See footnotes
Mina Kim SLRN Common Stock Disposed to Issuer -100% -770,833 0 21 May 2025 Direct
Mina Kim SLRN Common Stock Award 13.1% 89,526 770,833 21 May 2025 Direct
Mina Kim SLRN Employee Stock Option (right to buy) Disposed to Issuer -100% -1,833,915 0 21 May 2025 Direct
Bruce C. Cozadd SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -298,835 0 21 May 2025 Direct
Amar Murugan SLRN Common Stock Disposed to Issuer -100% -121,587 0 21 May 2025 Direct
Amar Murugan SLRN Employee Stock Option (right to buy) Disposed to Issuer -100% -525,000 0 21 May 2025 Direct
Beth C. Seidenberg SLRN Common Stock Disposed to Issuer -100% -9,790,729 0 21 May 2025 See footnote
Beth C. Seidenberg SLRN Common Stock Disposed to Issuer -100% -60,000 0 21 May 2025 Direct
Beth C. Seidenberg SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -115,401 0 21 May 2025 Direct
Shephard Mpofu SLRN Common Stock Disposed to Issuer -100% -121,789 0 21 May 2025 Direct
Shephard Mpofu SLRN Employee Stock Option (right to buy) Disposed to Issuer -100% -590,304 0 21 May 2025 Direct
Gosebruch Henry O SLRN Common Stock Disposed to Issuer -100% -50,000 0 21 May 2025 Direct
Gosebruch Henry O SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -247,608 0 21 May 2025 Direct
Patrick Machado SLRN Common Stock Disposed to Issuer -100% -14,675 0 21 May 2025 See footnote
Patrick Machado SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -270,849 0 21 May 2025 Direct
Dawn Svoronos SLRN Common Stock Disposed to Issuer -100% -15,000 0 21 May 2025 Direct
Dawn Svoronos SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -270,851 0 21 May 2025 Direct
Daniel J. Becker SLRN Common Stock Disposed to Issuer -100% -2,999 0 21 May 2025 Direct
Daniel J. Becker SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -115,401 0 21 May 2025 Direct
Lynn A. Tetrault SLRN Director Stock Option (right to buy) Disposed to Issuer -100% -133,635 0 21 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .